Can PPAR#947; Ligands Be Used in Cancer Therapy?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|4|6|465-477

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.6, 2004-11, pp. : 465-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Positron Emission Tomography (PET) be Used to Detect Subclinical Response to Cancer Therapy?

By Price P.   Jones T.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1924-1927

Elsevier

Access to resources Recommend Favorite

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 13, Iss. 1, 2018-01 ,pp. : 40-69

Bentham Science Publishers

Access to resources Recommend Favorite

The Electron Affinity of Some Radiotherapeutic Agents Used in Cancer Therapy

By Wold Einar   Kaalhus Olav   Johansen Erik Skipperud   Ekse Aud Tveito  

International Journal of Radiation Biology, Vol. 38, Iss. 6, 1980-12 ,pp. : 599-611

Informa Healthcare

Access to resources Recommend Favorite

The Antiproliferative Effects of PPAR Ligands in Normal Human Mammary Epithelial Cells

By Yee L.D.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 2, 2003-03 ,pp. : 179-192

Springer Publishing Company

Access to resources Recommend Favorite